A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants
Clinical trial NCT07007546 · COMPLETED
Trial details
- NCT number
- NCT07007546
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-17
- Primary completion
- 2025-07-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.